Animal Models of IBD-Associated CRC and Colorectal Cancer Tumorigenesis

被引:4
|
作者
Fu, Shuyi K. [1 ]
Lawrance, Ian C. [1 ,2 ]
机构
[1] Univ Western Australia, Fiona Stanley Hosp, Sch Med & Pharmacol, Harry Perkins Inst Med Res, Murdoch, WA, Australia
[2] St John God Hosp, Ctr inflammatory Bowel Dis, Subiaco, WA, Australia
关键词
colorectal cancer; animal model; tumorigenesis;
D O I
10.4137/CMT.S18489
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colorectal cancer (CRC) is a highly prevalent disease, and despite advances in medical research, much remains unknown about CRC. As such, it is important to improve our current understanding of CRC. Several animal models for CRC exist, and they provide an excellent tool for studying CRC tumorigenesis. These models, however, have limitations, and a good understanding of the pathophysiology of these models is required in order to fully understand how closely they mimic human sporadic and colitis-associated CRC.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] IBD-ASSOCIATED COLORECTAL CANCER HAS SIMILAR CHARACTERISTICS AND OUTCOMES COMPARED TO SPORADIC CRC
    Qwaider, Yasmeen Z.
    Sell, Naomi M.
    Boudreau, Chloe
    Ricciardi, Rocco
    Bordeianou, Liliana G.
    Cauley, Christy E.
    Hodin, Richard A.
    Berger, David L.
    Kunitake, Hiroko
    Goldstone, Robert N.
    GASTROENTEROLOGY, 2021, 160 (06) : S887 - S887
  • [2] Targeted Mutational Analysis in IBD-Associated Colorectal Cancer
    Alpert, Lindsay
    Yassan, Lindsay
    Kadri, Sabah
    Mujacic, Ibro
    Niu, Nifiang
    Montez, David
    Galbo, Filippo D.
    Wurst, Michelle N.
    Zhen, Chao J.
    Weber, Christopher
    Xiao, Shu-Yuan
    Hart, John
    Segal, Jeremy
    Setia, Namrata
    MODERN PATHOLOGY, 2017, 30 : 158A - 158A
  • [3] Targeted Mutational Analysis in IBD-Associated Colorectal Cancer
    Alpert, Lindsay
    Yassan, Lindsay
    Kadri, Sabah
    Mujacic, Ibro
    Niu, Nifang
    Montez, David
    Galbo, Filippo D.
    Wurst, Michelle N.
    Zhen, Chao J.
    Weber, Christopher
    Xiao, Shu-Yuan
    Hart, John
    Segal, Jeremy
    Setia, Namrata
    LABORATORY INVESTIGATION, 2017, 97 : 158A - 158A
  • [4] ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis
    Wang, Qiushi
    Zhang, Tianshun
    Chang, Xiaoyu
    Lim, Do Young
    Wang, Keke
    Bai, Ruihua
    Wang, Ting
    Ryu, Joohyun
    Chen, Hanyong
    Yao, Ke
    Ma, Wei-Ya
    Boardman, Lisa A.
    Bode, Ann M.
    Dong, Zigang
    CANCER RESEARCH, 2020, 80 (19) : 4158 - 4171
  • [5] Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared
    Rhodes, JM
    Campbell, BJ
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (01) : 10 - 16
  • [6] Germline Alterations in Patients With IBD-associated Colorectal Cancer
    Biscaglia, Giuseppe
    Latiano, Anna
    Castellana, Stefano
    Fontana, Rosanna
    Gentile, Annamaria
    Latiano, Tiziana
    Corritore, Giuseppe
    Panza, Anna
    Nardella, Marianna
    Martino, Giuseppina
    Bossa, Fabrizio
    Perri, Francesco
    Mazza, Tommaso
    Andriulli, Angelo
    Palmieri, Orazio
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (03) : 447 - 454
  • [7] IBD-ASSOCIATED CRC VS. NON-IBD ASSOCIATED CRC: A SEER MEDICARE STUDY
    Gearhart, S.
    Wick, E.
    Efron, J.
    Shore, A.
    DISEASES OF THE COLON & RECTUM, 2011, 54 (05) : E20 - E21
  • [8] Age-associated clinicopathological characteristics of IBD-associated colorectal cancer
    Ambelil, Manju
    Cao, Zongxian
    Ballentine, Samuel
    Liu, Qingqing
    Ko, Huaibin Mabel
    Zhu, Hongfa
    Polydorides, Alexandros
    Harpaz, Noam
    MODERN PATHOLOGY, 2019, 32
  • [9] Age-associated clinicopathological characteristics of IBD-associated colorectal cancer
    Ambelil, Manju
    Cao, Zongxian
    Ballentine, Samuel
    Liu, Qingqing
    Ko, Huaibin Mabel
    Zhu, Hongfa
    Polydorides, Alexandros
    Harpaz, Noam
    LABORATORY INVESTIGATION, 2019, 99
  • [10] Outcomes of IBD-associated colorectal cancer and implications in early-onset colorectal cancer
    Villarreal, Oscar
    Zeineddine, Fadl A.
    Chacko, Ray
    Parseghian, Christine Megerdichian
    Johnson, Benny
    Willis, Jason
    Lee, Michael Sangmin
    Morris, Van K.
    Dasari, Arvind
    Raghav, Kanwal Pratap Singh
    Overman, Michael J.
    You, Y. Nancy
    Wang, Yinghong
    Maru, Dipen M.
    Shen, John Paul Y. C.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)